Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

BUY
$3.36 - $4.81 $673,532 - $964,193
200,456 Added 60.23%
533,287 $1.97 Million
Q3 2019

Nov 14, 2019

BUY
$3.57 - $6.58 $122,208 - $225,246
34,232 Added 11.46%
332,831 $1.27 Million
Q1 2019

May 14, 2019

BUY
$5.19 - $8.97 $429,363 - $742,079
82,729 Added 38.32%
298,599 $2.47 Million
Q4 2018

Feb 14, 2019

BUY
$4.29 - $9.94 $926,082 - $2.15 Million
215,870 New
215,870 $1.06 Million
Q2 2018

Aug 14, 2018

SELL
$13.3 - $17.49 $864,500 - $1.14 Million
-65,000 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$12.26 - $18.98 $796,900 - $1.23 Million
65,000 New
65,000 $0

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $10.4M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.